![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 1, 277-286, January 5, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






1
From the
Departments of
Pharmacology and
Chemistry, University of Virginia, Charlottesville, Virginia 22908-0735
Brain, liver, kidney, heart, and skeletal muscle from fatty liver dystrophy (fld/fld) mice, which do not express lipin 1 (lipin), contained much less Mg2+-dependent phosphatidic acid phosphatase (PAP) activity than tissues from wild type mice. Lipin harboring the fld2j (Gly84
Arg) mutation exhibited relatively little PAP activity. These results indicate that lipin is a major PAP in vivo and that the loss of PAP activity contributes to the fld phenotype. PAP activity was readily detected in immune complexes of lipin from 3T3-L1 adipocytes, where the protein was found both as a microsomal form and a soluble, more highly phosphorylated, form. Fifteen phosphorylation sites were identified by mass spectrometric analyses. Insulin increased the phosphorylation of multiple sites and promoted a gel shift that was due in part to phosphorylation of Ser106. In contrast, epinephrine and oleic acid promoted dephosphorylation of lipin. The PAP-specific activity of lipin was not affected by the hormones or by dephosphorylation of lipin with protein phosphatase 1. However, the ratio of soluble to microsomal lipin was markedly increased in response to insulin and decreased in response to epinephrine and oleic acid. The results suggest that insulin and epinephrine control lipin primarily by changing localization rather than intrinsic PAP activity.
Received for publication, October 10, 2006 , and in revised form, November 14, 2006.
* This work was supported by National Institutes of Health Grants DK52753 and DK28312 (to J. C. L.) and GM37537 (to D. F. H.) and by the University of Virginia Diabetes and Endocrinology Research Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Pharmacology, P.O. Box 800735, 1300 Jefferson Park Ave., Charlottesville, VA 22908-0735. Tel.: 434-924-1584; Fax: 434-982-3878; E-mail: jcl3p{at}virginia.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Z. Chen, M. C. Gropler, J. Norris, J. C. Lawrence Jr, T. E. Harris, and B. N. Finck Alterations in Hepatic Metabolism in fld Mice Reveal a Role for Lipin 1 in Regulating VLDL-Triacylglyceride Secretion Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1738 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, L. O'Loughlin, D. N. Brindley, and K. Reue Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis J. Lipid Res., July 1, 2008; 49(7): 1519 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nadra, A.-S. d. P. Charles, J.-J. Medard, W. T. Hendriks, G.-S. Han, S. Gres, G. M. Carman, J.-S. Saulnier-Blache, M. H.G. Verheijen, and R. Chrast Phosphatidic acid mediates demyelination in Lpin1 mutant mice Genes & Dev., June 15, 2008; 22(12): 1647 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Manmontri, M. Sariahmetoglu, J. Donkor, M. B. Khalil, M. Sundaram, Z. Yao, K. Reue, R. Lehner, and D. N. Brindley Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically J. Lipid Res., May 1, 2008; 49(5): 1056 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Donkor, L. M. Sparks, H. Xie, S. R. Smith, and K. Reue Adipose Tissue Lipin-1 Expression Is Correlated with Peroxisome Proliferator-Activated Receptor {alpha} Gene Expression and Insulin Sensitivity in Healthy Young Men J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 233 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-S. Han, S. Siniossoglou, and G. M. Carman The Cellular Functions of the Yeast Lipin Homolog Pah1p Are Dependent on Its Phosphatidate Phosphatase Activity J. Biol. Chem., December 21, 2007; 282(51): 37026 - 37035. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Croce, J. C. Eagon, L. L. LaRiviere, K. M. Korenblat, S. Klein, and B. N. Finck Hepatic Lipin 1{beta} Expression Is Diminished in Insulin-Resistant Obese Subjects and Is Reactivated by Marked Weight Loss Diabetes, September 1, 2007; 56(9): 2395 - 2399. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Gowri, S. Sengupta, S. Bertera, and B. S. Katzenellenbogen Lipin1 Regulation by Estrogen in Uterus and Liver: Implications for Diabetes and Fertility Endocrinology, August 1, 2007; 148(8): 3685 - 3693. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim, M. S. Gentry, T. E. Harris, S. E. Wiley, J. C. Lawrence Jr, and J. E. Dixon A conserved phosphatase cascade that regulates nuclear membrane biogenesis PNAS, April 17, 2007; 104(16): 6596 - 6601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Donkor, M. Sariahmetoglu, J. Dewald, D. N. Brindley, and K. Reue Three Mammalian Lipins Act as Phosphatidate Phosphatases with Distinct Tissue Expression Patterns J. Biol. Chem., February 9, 2007; 282(6): 3450 - 3457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |